BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10702795)

  • 21. Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis.
    Buchhagen DL; Worsham MJ; Dyke DL; Carey TE
    Head Neck; 1996; 18(6):529-37. PubMed ID: 8902566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evidence for the inactivation of multiple replicative lifespan genes in immortal human squamous cell carcinoma keratinocytes.
    Loughran O; Clark LJ; Bond J; Baker A; Berry IJ; Edington KG; Ly IS; Simmons R; Haw R; Black DM; Newbold RF; Parkinson EK
    Oncogene; 1997 Apr; 14(16):1955-64. PubMed ID: 9150362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rare loss-of-function mutation of a death receptor gene in head and neck cancer.
    Pai SI; Wu GS; Ozören N; Wu L; Jen J; Sidransky D; El-Deiry WS
    Cancer Res; 1998 Aug; 58(16):3513-8. PubMed ID: 9721851
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alpha CP-4, encoded by a putative tumor suppressor gene at 3p21, but not its alternative splice variant alpha CP-4a, is underexpressed in lung cancer.
    Pio R; Zudaire I; Pino I; Castaño Z; Zabalegui N; Vicent S; Garcia-Amigot F; Odero MD; Lozano MD; Garcia-Foncillas J; Calasanz MJ; Montuenga LM
    Cancer Res; 2004 Jun; 64(12):4171-9. PubMed ID: 15205328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of p53 or p27 overexpression on cyclooxygenase-2 gene expression in head and neck squamous cell carcinoma cell lines.
    Lee DW; Park SW; Park SY; Heo DS; Kim KH; Sung MW
    Head Neck; 2004 Aug; 26(8):706-15. PubMed ID: 15287038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.
    Byun DS; Lee MG; Chae KS; Ryu BG; Chi SG
    Cancer Res; 2001 Oct; 61(19):7034-8. PubMed ID: 11585730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of LOX- and LOXL2-mRNA expression in head and neck squamous cell carcinomas.
    Rost T; Pyritz V; Rathcke IO; Görögh T; Dünne AA; Werner JA
    Anticancer Res; 2003; 23(2B):1565-73. PubMed ID: 12820424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of focal adhesion kinase in head and neck squamous cell carcinoma is independent of fak gene copy number.
    Canel M; Secades P; Rodrigo JP; Cabanillas R; Herrero A; Suarez C; Chiara MD
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3272-9. PubMed ID: 16740747
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inactivation of the human fragile histidine triad gene at 3p14.2 in monochromosomal human/mouse microcell hybrid-derived severe combined immunodeficient mouse tumors.
    Kholodnyuk ID; Szeles A; Yang Y; Klein G; Imreh S
    Cancer Res; 2000 Dec; 60(24):7119-25. PubMed ID: 11156420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display.
    Chung JG; Yeh KT; Wu SL; Hsu NY; Chen GW; Yeh YW; Ho HC
    Cancer Res; 2001 Dec; 61(24):8873-9. PubMed ID: 11751411
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of the human semaphorin III/F gene (SEMA3F) at chromosome 3p21, a region deleted in lung cancer.
    Xiang RH; Hensel CH; Garcia DK; Carlson HC; Kok K; Daly MC; Kerbacher K; van den Berg A; Veldhuis P; Buys CH; Naylor SL
    Genomics; 1996 Feb; 32(1):39-48. PubMed ID: 8786119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
    Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM
    Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deleted in colorectal cancer is a putative conditional tumor-suppressor gene inactivated by promoter hypermethylation in head and neck squamous cell carcinoma.
    Carvalho AL; Chuang A; Jiang WW; Lee J; Begum S; Poeta L; Zhao M; Jerónimo C; Henrique R; Nayak CS; Park HL; Brait MR; Liu C; Zhou S; Koch W; Fazio VM; Ratovitski E; Trink B; Westra W; Sidransky D; Moon CS; Califano JA
    Cancer Res; 2006 Oct; 66(19):9401-7. PubMed ID: 17018594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mutation and expression of SEMA3B and SEMA3F gene in nasopharyngeal carcinoma].
    Liu XQ; Sun M; Chen HK; Li JX; Pan ZG; Long QX; Wang XZ; Zeng YX
    Ai Zheng; 2003 Jan; 22(1):16-20. PubMed ID: 12561429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas.
    Yi Lo PH; Chung Leung AC; Xiong W; Law S; Duh FM; Lerman MI; Stanbridge EJ; Lung ML
    Cancer Lett; 2006 Mar; 234(2):184-92. PubMed ID: 15885884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The 3p21 candidate tumor suppressor gene BAF180 is normally expressed in human lung cancer.
    Sekine I; Sato M; Sunaga N; Toyooka S; Peyton M; Parsons R; Wang W; Gazdar AF; Minna JD
    Oncogene; 2005 Apr; 24(16):2735-8. PubMed ID: 15735765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alternative splicing of c-fos pre-mRNA: contribution of the rates of synthesis and degradation to the copy number of each transcript isoform and detection of a truncated c-Fos immunoreactive species.
    Jurado J; Fuentes-Almagro CA; Prieto-Alamo MJ; Pueyo C
    BMC Mol Biol; 2007 Sep; 8():83. PubMed ID: 17888145
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutational inactivation of aminoacylase-I in a small cell lung cancer cell line.
    Cook RM; Franklin WA; Moore MD; Johnson BE; Miller YE
    Genes Chromosomes Cancer; 1998 Apr; 21(4):320-5. PubMed ID: 9559343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ; Ahsan H; Chen Y; Lunn RM; Wang LY; Chen SY; Lee PH; Chen CJ; Santella RM
    Mol Carcinog; 2002 Oct; 35(2):85-92. PubMed ID: 12325038
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.